New York Stock Exchange-listed pharmaceutical research and development services provider WuXi PharmaTech (Cayman) Inc. has completed a US$3.3 billion go-private deal, in which it has been acquired by a group of private equity investors and company management, according to an announcement. The investor consortium includes Ally Bridge Group, Boyu Capital, units of Ping An Insurance […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.